These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6195859)

  • 1. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attachment of eosinophils at the basement membrane zone mediated by complement-fixing antibasement membrane zone antibody].
    Iwatsuki K; Tagami H; Yamada M
    Nihon Hifuka Gakkai Zasshi; 1982 Dec; 92(14):1503-9. PubMed ID: 6985225
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE
    J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T; Hashimoto T; Hibi T; Nishikawa T
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J
    J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015
    [No Abstract]   [Full Text] [Related]  

  • 9. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
    Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
    J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus antibodies mediate the development of an inflammatory change in the epidermis. A possible mechanism underlying the feature of eosinophilic spongiosis.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(6):495-500. PubMed ID: 6198838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sodium-chloride separated human skin in detection of circulating anti-basement membrane zone antibodies.
    Rasmussen HB; Brandrup F; Andersen J; Hagdrup H
    Acta Derm Venereol; 1989; 69(6):515-9. PubMed ID: 2575326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG; Brody N
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trials on bulla induction by antibodies from bullous pemphigoid patients in vivo and in vitro].
    Lohrisch I; Noack H; Haustein UF; Sparmann G; Koch J
    Dermatol Monatsschr; 1985; 171(2):106-12. PubMed ID: 3884399
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of IgG-subclass antibody determinations in bullous pemphigoid.
    Kumar V; Valeski JE; Chorzelski TP; Jablonska S
    J Clin Lab Anal; 1996; 10(6):432-4. PubMed ID: 8951615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papules with basement membrane zone antibodies preceding bullous pemphigoid.
    Lorette G; Fetissoff F
    Arch Dermatol; 1982 Nov; 118(11):878-9. PubMed ID: 6753763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.